Sign inJoin waitlistJoin the waitlist

Aude Chapuis

Adjunct Associate Professor · University of Washington School of Medicine

Credentials: · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Hematology and Medical Oncology
2000–2003
Internal Medicine
1997–2000
UNIV DE LAUSANNE, FAC DE MED, LAUSANNE, SWITZERLAND
1993–1997
University of Maryland

Research

Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics
Journal of the American Academy of Dermatology · 2018 · 414 citations
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
Blood · 2019 · 359 citations
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells
Blood · 2019 · 306 citations

Philip Greenberg
18 papers
KP
Kelly Paulson
16 papers · 5 as a resident
Filippo Milano
12 papers · 2 as a fellow
CT
Cameron Turtle
11 papers
David Maloney
11 papers
Brian Till
10 papers
David Koelle
10 papers
Cecilia Yeung
9 papers
Jordan Gauthier
9 papers · 3 as a fellow
Mazyar Shadman
9 papers
Paul Nghiem
9 papers · 1 as a fellow
Shailender Bhatia
9 papers

Grants

Immunobiology and Immune Therapy for Merkel Cell Carcinoma
National Cancer Institute · P01
Project lead · $1.4M · University of Washington
2019–2030
Adult Leukemia Research Center
National Cancer Institute · P01
Project lead · $2.9M · Fred Hutchinson Cancer Center
1997–2029
Targeting Tregs in the Solid Tumor Microenvironment by Modulating Metabolite Signaling
National Cancer Institute · R21
Contact PI · $452.5K · Fred Hutchinson Cancer Center
2024–2026
Targeting Leukemia with Memory CD8+ T Cells Transduced to Express High-Affinity W
National Cancer Institute · K08
Contact PI · $856.9K · Fred Hutchinson Cancer Research Center
2013–2018

Clinical trials

Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2017–2020
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Principal investigator · Terminated · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2015–2018
Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Principal investigator · Terminated · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2013–2016
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
Principal investigator · Terminated · Phase 1, Phase 2
Fred Hutchinson Cancer Center
2012–2020